Step 1: Nitric oxide (NO) is released from endothelium and diffuses to the surrounding vascular smooth muscle cells.
Step 2: In the smooth muscle, NO activates guanylate cyclase, which increases cyclic guanosine monophosphate (cGMP), a cyclic nucleotide derived from GTP. So option 4 is correct.
Step 3: cGMP acts as a second messenger, much like cyclic AMP, activating intracellular protein kinases that cause smooth muscle relaxation and vasodilation.
Step 4: BRCA1 and BRCA2 are tumor-suppressor genes and interleukins are cytokines; none of them is the second messenger of NO, so options 1, 2, and 3 are wrong.